Ralph Niven

Ralph Niven

Technik-/Wissenschafts-/F&E-Leiter bei AEROVATE THERAPEUTICS, INC.

Vermögen: 28 077 $ am 31.05.2024

64 Jahre
Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von Ralph Niven

EinheitArt der EinheitIndustrie
33
Subsidiary Pharmaceuticals: Major 33
Public Company Biotechnology 17
Public Company Pharmaceuticals: Major 10
9
Extinct Biotechnology 9

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Ralph Niven

UnternehmenSektorVerknüpfte PersonenHauptposition
NOVARTIS AG Pharmaceuticals: Major

Anthony Adam Rosenberg

David Epstein

André Wyss

Alessandro Riva

Thomas N. Kendris

Paul Hudson

William Ludlam

Corporate Officer/Principal

Corporate Officer/Principal

Chief Operating Officer

Corporate Officer/Principal

General Counsel

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

David Epstein

Meryl Zausner

Alessandro Riva

Thomas N. Kendris

Herve Hoppenot

Christi Shaw

Steven Stein

Chief Executive Officer

Director of Finance/CFO

President

General Counsel

President

Corporate Officer/Principal

Corporate Officer/Principal

AIMMUNE THERAPEUTICS, INC. Pharmaceuticals: Major

Stephen Dilly

Mark Iwicki

Le-Van Nguyen

Chief Executive Officer

Director/Board Member

Corporate Officer/Principal

Biotechnology

Stephen Dilly

Charles A. Johnson

Amy Burroughs

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

Medical Specialties

Camille Samuels

Timothy Noyes

Ralph Kern

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Harvard Business School College/University

Camille Samuels

Timothy Noyes

Amy Burroughs

Masters Business Admin

Masters Business Admin

Masters Business Admin

College/University

Camille Samuels

Rhonda Nesmith Crichlow

Kala Subramanian

Undergraduate Degree

Graduate Degree

Graduate Degree

Miscellaneous Commercial Services

Herve Hoppenot

Christi Shaw

Habib Dable

Director/Board Member

Director/Board Member

Director/Board Member

Columbia Business School College/University

David Epstein

Roger Waltzman

Kathy Yi

Masters Business Admin

Masters Business Admin

Masters Business Admin

Pharmaceuticals: Major

Meryl Zausner

André Wyss

Thomas N. Kendris

Director of Finance/CFO

President

President

Investment Managers

Dave Grayzel

Mark Iwicki

Joshua Resnick

Private Equity Investor

Consultant / Advisor

Private Equity Investor

Fairleigh Dickinson University College/University

Thomas Miller

Kathleen A. McGowan

Masters Business Admin

Masters Business Admin

Stanford University College/University

Dave Grayzel

Joe Melvin

Undergraduate Degree

Masters Business Admin

Pharmaceuticals: Major

Joshua Resnick

Andrew Levin

Director/Board Member

Director/Board Member

University of Delaware College/University

Cathryn Clary

Timothy M. Wright

Masters Business Admin

Undergraduate Degree

Medical Specialties

Mary Christina Thomson

Stephen Dilly

General Counsel

Director/Board Member

BRAINSTORM CELL THERAPEUTICS INC. Biotechnology

Arturo O. Araya

Ralph Kern

Director/Board Member

President

Investment Managers

Mark G. Osterman

W. Amick

Corporate Officer/Principal

Corporate Officer/Principal

Medical Specialties

Mark G. Osterman

Thomas Miller

Director/Board Member

Sales & Marketing

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Arturo O. Araya

Viera Muzithras

Sales & Marketing

General Counsel

AXCA HEALPAR Biotechnology

Paul Sekhri

David Epstein

Director/Board Member

Chairman

Biotechnology

Dave Grayzel

Mark Iwicki

Founder

Chairman

Rutgers State University of New Jersey College/University

Vincent J. Benn

Viera Muzithras

Doctorate Degree

Undergraduate Degree

Temple University (Pennsylvania) College/University

Vincent J. Benn

Jerome Riebman

Masters Business Admin

Graduate Degree

Pharmaceuticals: Major

Steven J. Gavel

Kala Subramanian

Sales & Marketing

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

Timothy Noyes

Mark Iwicki

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Manuel Litchman

Pierre-Alain Ruffieux

Corporate Officer/Principal

Corporate Officer/Principal

JOHNSON & JOHNSON Pharmaceuticals: Major

Kathleen A. McGowan

Christi Shaw

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Jonathan Leff

Maha Katabi

Director/Board Member

Director/Board Member

OYSR POIN Pharmaceuticals: Major

Donald Santel

Eric Carlson

Chairman

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Donald Santel

Camille Samuels

Chairman

Director/Board Member

Medical Specialties

Christi Shaw

Jerome Riebman

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

PROTARA THERAPEUTICS, INC. Pharmaceuticals: Major

George Eldridge

Timothy Noyes

Director of Finance/CFO

Chief Executive Officer

Investment Managers

David Epstein

Kala Subramanian

Private Equity Investor

Private Equity Investor

THESEUS PHARMACEUTICALS, INC. Biotechnology

Steven Stein

Kathy Yi

Director/Board Member

Director/Board Member

Dartmouth College College/University

George Eldridge

Amy Burroughs

Undergraduate Degree

Undergraduate Degree

Investment Managers

Jonathan Leff

Maha Katabi

Private Equity Investor

Private Equity Investor

Pharmaceuticals: Major

Kathleen A. McGowan

Steven J. Gavel

Corporate Officer/Principal

Corporate Officer/Principal

ASTRAZENECA PLC Pharmaceuticals: Major

Paul Hudson

Donna Dea

Corporate Officer/Principal

Corporate Officer/Principal

INTERMUNE INC Biotechnology

Jonathan Leff

Le-Van Nguyen

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

University of Pennsylvania College/University

Jonathan Leff

Steven Stein

Undergraduate Degree

Corporate Officer/Principal

AMGEN INC. Pharmaceuticals: Major

Jonathan Leff

Jerome Riebman

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

INCYTE CORPORATION Pharmaceuticals: Major

Herve Hoppenot

Steven Stein

Chief Executive Officer

Chief Tech/Sci/R&D Officer

Investment Managers

Camille Samuels

Carlo Rizzuto

Private Equity Investor

Private Equity Investor

Biotechnology

Paul Sekhri

Carlo Rizzuto

Corporate Officer/Principal

Chief Executive Officer

Statistik

International

Vereinigte Staaten 46
Schweiz 3
Niederlande 2
Vereinigtes Königreich 2

Sektoral

Health Technology 34
Consumer Services 11
Finance 6
Commercial Services 2

Operativ

Director/Board Member 296
Corporate Officer/Principal 188
Independent Dir/Board Member 87
Undergraduate Degree 56
President 55
  1. Börse
  2. Insiders
  3. Ralph Niven
  4. Unternehmensverbindungen